Biofrontera (BFRIW) Total Non-Current Liabilities (2020 - 2025)
Biofrontera has reported Total Non-Current Liabilities over the past 6 years, most recently at $17.7 million for Q4 2025.
- Quarterly results put Total Non-Current Liabilities at $17.7 million for Q4 2025, up 8.01% from a year ago — trailing twelve months through Dec 2025 was $17.7 million (up 8.01% YoY), and the annual figure for FY2025 was $17.7 million, up 8.01%.
- Total Non-Current Liabilities for Q4 2025 was $17.7 million at Biofrontera, up from $17.2 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for BFRIW hit a ceiling of $36.2 million in Q4 2021 and a floor of -$8.6 million in Q2 2023.
- Median Total Non-Current Liabilities over the past 5 years was $21.2 million (2022), compared with a mean of $20.1 million.
- Biggest five-year swings in Total Non-Current Liabilities: crashed 130.38% in 2023 and later soared 213.11% in 2024.
- Biofrontera's Total Non-Current Liabilities stood at $36.2 million in 2021, then dropped by 25.52% to $27.0 million in 2022, then fell by 29.85% to $18.9 million in 2023, then dropped by 13.27% to $16.4 million in 2024, then increased by 8.01% to $17.7 million in 2025.
- The last three reported values for Total Non-Current Liabilities were $17.7 million (Q4 2025), $17.2 million (Q3 2025), and $24.3 million (Q2 2025) per Business Quant data.